Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus.
about
Laser in situ keratomileusis in patients with collagen vascular disease: a review of the literatureNon-invasive imaging to monitor lupus nephritis and neuropsychiatric systemic lupus erythematosusUnmet medical needs in systemic lupus erythematosusBaseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.Clinical and prognostic value of autoantibodies in puerto Ricans with systemic lupus erythematosus.SLE disease patterns in a Danish population-based lupus cohort: an 8-year prospective study.Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study.Mesangial cell-binding activity of serum immunoglobulin g in patients with lupus nephritisConcentrations of circulating matrix metalloproteinase 9 inversely correlate with autoimmune antibodies to double stranded DNA: implications for monitoring disease activity in systemic lupus erythematosus.Differential efficacy of human mesenchymal stem cells based on source of origin.Abetimus sodium: a new therapy for delaying the time to, and reducing the incidence of, renal flare and/or major systemic lupus erythematosus flares in patients with systemic lupus erythematosus who have a history of renal disease.Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity.Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-DNA antibody tests.Clinical laboratory assays for measuring anti-dsDNA antibodies. Where are we now?Lowering anti-dsDNA antibodies--what's new?Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice.The value of a panel of autoantibodies for predicting the activity of lupus nephritis at time of renal biopsy.Detection of autoantibodies in a point-of-care rheumatology setting.Mycophenolate mofetil prevents a clinical relapse in patients with systemic lupus erythematosus at risk.First clinical trials of a new heteropolymer technology agent in normal healthy volunteers and patients with systemic lupus erythematosus: safety and proof of principle of the antigen-heteropolymer ETI-104Anti-dsDNA-NcX ELISA: dsDNA-loaded nucleosomes improve diagnosis and monitoring of disease activity in systemic lupus erythematosus.Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time.Predictors of kidney disease in a cohort of pediatric patients with lupusBAFF (B cell activating factor) transcript level in peripheral blood of patients with SLE is associated with same-day disease activity as well as global activity over the next year.Predictive value of autoantibodies for activity of systemic lupus erythematosus.Lupus nephritis: a review of the current pharmacological treatments.High-throughput methods for measuring autoantibodies in systemic lupus erythematosus and other autoimmune diseases.Disease activity assessment in SLE: do we have the right instruments?Epidermal injury promotes nephritis flare in lupus-prone mice.Quantitation of autoantibodies in systemic autoimmune diseases: clinically useful?Detection of antibodies to dsDNA: an overview of laboratory assays.Mannose binding lectin: a biomarker of systemic lupus erythematosus disease activity.Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupusCorrelation between Systemic Lupus Erythematosus Disease Activity Index, C3, C4 and Anti-dsDNA Antibodies.Predictors of the rate of change in disease activity over time in LUMINA, a multiethnic US cohort of patients with systemic lupus erythematosus: LUMINA LXX.Elevated signal transducers and activators of transcription 1 correlates with increased C-C motif chemokine ligand 2 and C-X-C motif chemokine 10 levels in peripheral blood of patients with systemic lupus erythematosus.Pediatric SLE--towards a comprehensive management plan.Treat-to-target in systemic lupus erythematosus: recommendations from an international task force.Biomarkers in lupus nephritis.What Causes Lupus Flares?
P2860
Q24613130-49257263-AA01-4214-BDAF-DC07959B4FFEQ26796871-C114DFB4-0E79-4FC3-8E73-452551C58AE0Q27005906-38B353E5-4F31-4B2B-AC70-F36F9D0F4BF1Q30645037-CFCFB2C5-F525-400D-8780-5D19D07A0B11Q33373809-32F7DF39-E744-4BFA-89A9-8544A5ADDEF3Q33387223-4908E1A0-D4E0-4F6A-A769-772EB6A3428AQ33743791-F0C712EA-DE69-4A03-94E9-DC5D59F12C13Q33875182-7FA9E7C5-003C-4598-8307-CA8002C674A3Q33919215-9889B013-F941-4A72-B50A-196AB5B496BBQ34364745-75B3D978-569E-4202-BC10-D508DEA974FFQ34555048-18ADAE83-5A02-4B5E-88D2-40E600ECCF24Q34720014-EF4DC1F9-8012-4BD0-8713-5641CE4BED63Q34968807-21096518-C799-41A0-91C7-9EE1FE248767Q35045883-7EE35EDD-7243-4FE8-8EB2-D6AC3715EF13Q35045927-8D2593FF-67B8-49C6-9084-D239FC35F525Q35060808-BB27CAC4-26B0-48D7-A1E5-79F5D9F64793Q35169740-88B34B61-7C48-4CF0-8B91-214490D268F2Q35309576-1F4B9FD0-8623-469F-B60F-24929339F878Q35552758-C56FB1DB-702F-42F3-862B-5F4513C83C8CQ35554489-25453EF4-1271-463C-9BFC-BCC8AE3B825CQ35620345-9D972A96-C0D8-4C93-96C5-16CFF86B37A2Q35637820-B82D2EB6-F351-4740-A162-11ED9EEB79BDQ35738664-8D757D99-FB9B-4851-84BC-56776D874007Q35768902-7428C527-DC21-4517-B990-25FC5997F4B5Q35824462-2120F1AD-1B35-46C2-9595-DA51516B5FEDQ35925513-0FEE03C2-12E8-4F9F-BEC9-5D799EBBE7E0Q35934672-5B5E640D-318D-4B69-9ADD-1B72C84175B9Q36171764-C312AB70-CCB0-4897-9908-37BED4719E53Q36373291-E374A074-0CE0-4BDF-A678-40E93CB4AC1EQ36560767-3DDC238D-2925-43F2-9005-F0E0C7F719FBQ36560773-A14FC773-5E10-4869-8F83-7B729DB83906Q36633215-66C6FA3F-803A-4462-9BB1-079B483D8549Q36966870-B75CF2BF-6988-41BF-9CB0-8544ABD44197Q37037746-849BDE2C-6504-4CF1-A63E-2BE4E5126CDDQ37659608-C9D72637-4850-4274-8A8D-D32D8D8B5541Q37690029-F84F250A-71C1-42B3-9419-543EC8564787Q37850999-3505D4E0-A6AC-46E3-893D-DB53C9C7B92AQ38205079-B1C20EA8-3AF4-4CD4-9519-2B719997B369Q38425837-C5AB313F-2532-46A8-B59A-993ACFB730EDQ38764104-901509BF-6F77-47E7-9C4E-0829AF416745
P2860
Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Decreases in anti-double-stran ...... systemic lupus erythematosus.
@en
Decreases in anti-double-stran ...... systemic lupus erythematosus.
@nl
type
label
Decreases in anti-double-stran ...... systemic lupus erythematosus.
@en
Decreases in anti-double-stran ...... systemic lupus erythematosus.
@nl
prefLabel
Decreases in anti-double-stran ...... systemic lupus erythematosus.
@en
Decreases in anti-double-stran ...... systemic lupus erythematosus.
@nl
P2093
P2860
P1476
Decreases in anti-double-stran ...... systemic lupus erythematosus.
@en
P2093
P2860
P304
P356
10.1002/1529-0131(200110)44:10<2342::AID-ART397>3.0.CO;2-8
P577
2001-10-01T00:00:00Z